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Abstract 
Objective: The current systematic review aims to provide an overview of fear of cancer 
recurrence (FCR) in adolescent and young adult cancer survivors (15-39 yrs at cancer 
diagnosis, AYAs). 
Methods: MEDLINE, PubMed, PsycINFO and Embase databases were independently 
searched to identify relevant quantitative articles. PRISMA systematic review procedures 
were followed with quality assessment. 
Results: Seventeen studies were included in the current review. All were quantitative studies 
that utilized a cross-sectional study design. Seven articles reported results of FCR prevalence, 
six studied determinants related to FCR and eleven articles provided information about 
consequences of FCR. Prevalence of FCR ranged from 31% to 85.2% among AYA survivors. 
Associations between sociodemographic/clinical variables and FCR were inconsistent. 
Psychological distress, and higher treatment intensity were positively associated with higher 
FCR levels. Lower scores on levels of physical, psychological functioning and overall health-
related Quality of Life (QoL) were identified as consequences of increased FCR. 
Conclusion: FCR appears to be a prevalent concern among adolescent and young adult 
cancer populations. Adequate assessment to determine need for support and intervention is 
still required. Longitudinal studies in AYAs are warranted to understand the development 
and potential influence of FCR. Age-appropriate and flexible psychological care would be 
more successful potentially with this crucial background information. 
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1. Introduction 
Many different labels have been utilized to describe fears about the spread or relapse of 
cancer, such as fear of recurrence/fear of cancer recurrence (FoR or FCR) [1], fear of 
progression (FoP) [2], or worry/concern about disease return [3] etc. However, researchers 
tend to believe that these descriptions are virtually comparable on a conceptual level [2, 4, 
5], and for practical purposes, there is indeed very strong overlap among them. In this 
review, the term FCR was used. FCR is commonly defined as: fear, worry, or concern relating 
to the possibility that cancer will come back or progress [6]. Patients with high FCR often 
report significant psychological distress (i.e. depression, anxiety), increased health service 
use [7, 8], as well as negative behavior changes (i.e. avoidance, excessive personal self-
examination behaviors) [9-12]. This concern may appear immediately after cancer diagnosis 
or treatment and has been shown to remain stable for years [13]. 
 
Recent studies have shown that about 24-40% of the survivors reported moderate to high 
levels of need for help dealing with their FCR [14-16]. Studies consistently reported that 
survivors diagnosed at a young age, female gender, and patients with more physical 
symptoms were more likely to experience higher FCR [14, 17]. Meta-analysis showed that 
having had a mastectomy [4], radiotherapy [18] or chemotherapy [19] were significantly 
related to elevated fear level. A recent study indicated that psychological factors play a 
stronger role in FCR than demographic or clinical factors [20]. Lebel et al., found that a 
patient’s FCR was significantly predicted by the individual’s perceived risk of recurrence, 
illness uncertainty, and triggers [7]. Smith and colleagues indicated that negative 
metacognitive beliefs, as well as intrusive post-traumatic stress symptoms were independent 
correlates of FCR, which accounted for 26% and 28% of the total observed variance, 
respectively [21]. Another large sample study in Chinese cancer patients revealed that 
higher stress, anxiety, depressive symptom and personality (pessimism) were significant 
predictors of FCR, and hierarchical regression analysis showed that sociodemographic and 
clinical factors only accounted for 6.9% of the variance of FCR while psychological variables 
explained 33.1% of the total variance [22]. 
 
Many reviews have been conducted to provide overall knowledge about FCR in adult 
survivors. The first literature review on FCR was published in 1997 by Lee-Jones and 
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colleagues [1]. Since the publication of the first review, FCR research has expanded 
considerably. In recent years, Crist et al. [23] performed a systematic review to identify key 
variables associated with FCR and eventually included 43 studies in the article. They 
reported the most consistent predictor of elevated FCR was younger age, and revealed that 
low optimism, family stressors as well as fewer significant others were additional important 
factors moderately associated with higher FCR. Simard and his colleagues [17] performed 
the most recent and robust review of quantitative studies in 2013 by searching more 
databases and identified 130 eligible articles. They concluded that younger age, 
psychological distress, and lower quality of life (QoL) were consistently associated with 
increased FCR, and family caregivers tended to report higher FCR than the patients. In the 
same year, Koch et al. [4] completed a systematic review in long-term cancer survivors 
(above 5 years since diagnosis). They reported that survivors suffered from FCR even years 
after initial cancer diagnosis, and studies including long-term and short-term survivors 
showed no significant change of FCR over time. In addition, reviews concentrating on 
specific cancer populations were also conducted. In 2015, a review by Ozga et al. [24] was 
published and it concluded that hopelessness, anxiety about death, uncertainty of the 
future, faith and more PTSD symptoms were significantly related to FCR in ovarian cancer 
survivors. 
 
Even though these FCR literature reviews have been published since 1997, and previous 
research has consistently showed that young age was significantly associated with increased 
FCR, this relationship has only been observed in adult samples, and no review has focused 
specifically on how FCR manifests itself in adolescent and young adult (AYA) cancer survivors. 
However, cancer is the leading cause of disease-related death among AYAs [25], and recently 
national AYA programs have been attempted to fill the gap between the pediatric and adult 
oncology services and to provide better support for AYAs cancer patients [26]. We believe 
these features indicate an important need to conduct a specifically targeted systematic 
overview of FCR in adolescent and young adults. 
 
There are different definitions of the AYAs among countries [26]. In a recent report WHO 
summarizes that adolescents and youth are referred to as young people, encompassing the 
ages of 10 to 19 years [27]. In the United States, adolescent and young adults are patients 
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aged between 15 to 39 years at cancer diagnosis. However, in the UK, the spectrum of AYAs 
are patients aged between 13 to 24 years. Other countries, such as Netherlands, consider 
patients aged of 18 to 35 years at diagnosis as AYAs, while some other countries have not yet 
set a clear definition of it. 
 
In the current review, we use the US definition of AYAs in order to include more eligible 
studies. It has been reported that around 70,000 AYAs are diagnosed with cancer every year 
in the US, which accounts for nearly 5% of the total cancer diagnoses in the country [28]. 
Research also reported that AYAs are more likely than either younger persons or older adults 
to be diagnosed with certain types of cancer, such as leukemia, testicular cancer, thyroid 
cancer and Hodgkin lymphoma, and the most common cancers in AYAs are: brain, breast, 
cervical and colorectal cancer [28]. However, the unique genetic and biological features of 
adolescent and young adult cancer patients were still unclear. 
 
In all, the majority of existing studies on FCR has been performed with mixed-age samples or 
adult samples of breast cancer patients. It is still unclear how FCR behaves among AYA 
cancer survivors. This current review focuses on this special group of people aged between 
15 to 39 years old at cancer diagnosis and aims to assess the prevalence, potential 
determinants (i.e. correlates or predictors) and consequences/outcomes of FCR among AYAs. 
 
2. Methods 
Literature search 
MEDLINE, PubMed, PsycINFO and Embase databases were systematically and independently 
searched by two authors (HMW and WJL), from their inception until 1st September 2018, to 
identify relevant articles. No restrictions were placed on publication date. PRISMA 
systematic review procedures were followed including a quality assessment (the PRISMA 
checklist is presented in supplementary file 1) [29]. The systematic review was registered on 
PROSPERO on 11th Oct 2018, and the registration number is: CRD42018112306. 
 
The key search terms were: (“fear” [Mesh] or worry or concern), (“neoplasm” [Mesh] or 
cancer or carcinoma), (“recurrence” [Mesh] or progression or return or relapse), and 
(“adolescent” [Mesh] or teenager or teens or “young adult” [Mesh] or youngster or young or 
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AYA). Searching was conducted using the ‘OR’ and ‘AND’ functions. The detailed strategy and 
search result of each database is outlined in supplementary file 2. The references in 
identified articles were also screened manually for any additional relevant studies. 
 
Inclusion and exclusion criteria 
Studies were screened for eligibility before inclusion. According to the PICOS acronym, to be 
included in this review, references had to meet the following criteria: Participants (P): AYAs 
aged between 15 to 39 years at cancer diagnosis; Interventions (I): NA; Comparisons (C): NA; 
Outcomes (O): quantitative FCR results on prevalence, influencing factor, and consequence; 
Study Design (S): cross-sectional, longitudinal or RCT studies. Papers needed to be written in 
English and published in peer-reviewed journal. References were excluded if they were 
conference abstracts, editorials, commentaries, dissertations, review articles, or case 
studies. Studies using similar, however not accurate keywords such as ‘fear of dying’, ‘fear of 
the future’ or ‘fear of the worst happening’ were also excluded. Studies that compared FCR 
outcomes between AYA group and older adult group were included in the review, but only 
when FCR results of AYAs were reported. References were screened for eligibility by two 
authors (YY and YHW). 
 
Data extraction 
Titles and abstracts of potential eligible records were reviewed after removing duplicate 
studies, then unsuitable articles were excluded. Full papers were subsequently obtained and 
examined. Only papers that fulfilled the full inclusion criteria for the review were kept. For 
each study, the following data were extracted: 1) first author’s name, 2) year of publication, 
3) country of study, 4) study design, 5) basic sociodemographic and clinical/treatment 
information of the study sample (such as age at diagnosis and at survey, gender percentage, 
time since diagnosis), 6) FCR measurement, and 7) main findings of the study (i.e. FCR 
prevalence, potential determinants and outcomes). The independent variables of the 
original article were classified as the 'potential determinants', while the dependent variables 
were considered as the 'outcomes/consequences'. 
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Quality assessment 
The quality of each included article was assessed using the Standard Quality Assessment 
Criteria for quantitative studies (QualSyst criteria) [29]. Items were scored on the specific 
criteria (Yes = 2, Partial = 1, or No = 0). Items not applicable to a particular study design were 
marked ‘N/A’ and were excluded from the calculation of the total quality score. A summary 
quality score was calculated for each study by summing the total score obtained across 
relevant items and dividing by the total possible score (i.e.: 28-(number of ‘N/A’ x 2)). Strong 
quality was defined as (> 0.80), good quality (0.70‐0.80), adequate quality (0.50‐0.70), or 
limited quality (<0.50) [29]. The quality assessment was conducted by two researchers 
independently (YY and YHW). In situations of disagreement of a study, another researcher 
(LW) repeated the assessment and in discussion reached consensus. Senior author (HWS) 
overviewed the procedures. 
 
3. Results 
Study selection 
The search process is presented in Figure 1. The literature search of Pubmed, Embase, 
PsycINFO and MEDLINE databases identified 1004 references. After duplicates were 
excluded, 835 records remained. Examination of titles and abstracts for appropriateness left 
58 articles. After retrieving full texts and further evaluation, 17 studies were included in the 
systematic review. All the included studies were assessed by the QualSyst criteria, and none 
were scored as limited quality. Detailed scores of quality assessment are showed in 
supplementary file 3. 
 
Characteristics of included studies 
The publication dates of the studies ranged from 1997 to 2018 (two articles were published 
in the 1990s [30, 31], three in the 2000s [32-34], and the remaining articles were all 
published since 2010). Nine studies were conducted in the US, two each in Canada, 
Netherlands, and Germany, and one each in Sweden and Finland. Sample size varied from 20 
to 1395. Three studies concentrated specifically on AYA breast cancer survivors [32, 35, 36], 
one focused on gynecological cancer [37], one on leukemia [30], eleven articles studied 
mixed AYA cancer populations, and one did not report cancer type [38]. 
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Eleven studies reported both age at cancer diagnosis and age at survey, two studies only 
reported age at diagnosis [26, 36] and 4 only reported age at survey [31, 32, 35, 39]. As for 
FCR measurement, questionnaire(s) were frequently utilized (as opposed to standardized 
clinical interview). The number of scale items ranged from 1 to 30, and only eight studies 
utilized a validated instrument, such as Cancer Worry Scale (CWS), Concerns About 
Recurrence Scale (CARS) and Fear of Progression Questionnaire-short form (FoP-SF). Four 
studies used a single FCR question [25, 31, 32, 40] and five used study-specific questions. In 
all, seven articles reported results of FCR prevalence, six of them studied determinants 
related to FCR and 11 articles provided information about consequences of FCR. Main 
characteristics and findings of the included articles are presented in Table 1. 
 
Prevalence of FCR 
Seven articles reported prevalence data on FCR [25, 26, 30, 32, 37, 41, 42]. Thewes [26] and 
colleagues investigated 73 adolescents and young adults (aged 18-35) and found 45 of them 
(62%) reported high levels of FCR (CWS total score ≥14). This finding is similar to Mattsson’s 
study which reported 185 out of 286 (61%) of young gynecological cancer survivors 
experienced FCR [37], but it is inconsistent with Wang’s study which found that only 7% of 
the AYAs reported strong worry about recurrence (rated as ‘strongly agree’) [42]. Another 
study with 292 survivors showed that about half of the participants experienced moderate-
to-high recurrence fear (2≤FCR mean score<3), but only 13% of them reported high level of 
FCR (mean score=3) [41]. Puukko et al. also suggested that around 52% of survivors 
experience FCR. However, a much higher figure (85.2%) was reported in a large sample study 
of 1395 AYAs using a single FCR question derived from the Quality of Life in Adult Cancer 
Survivors Scale [25]. Only one study reported longitudinal outcomes of FCR prevalence, this 
study revealed that about 29% of AYA survivors reported FCR at study baseline, and the 
percentage slightly increased at one-year follow up (31%), which indicated that FCR tended 
to remain stable in AYAs. Overall, across different cancer types and evaluation strategies, 
29% to 85.2% of AYA survivors reported some degree of FCR [25, 30, 32, 37], 31% to 49.1% 
reported moderate to high level of FCR [41, 42] and 13% to 62% reported high level of FCR 
[26, 42]. 
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Determinants of FCR 
Potential determinants of FCR were classified into three groups (demographic, 
clinical/treatment, and psychological) according to conceptual similarity. In those studies 
where both univariate and multivariate analyses were employed, multivariate results were 
presented preferentially. In all, six studies investigated determinants related to FCR [25, 26, 
35, 37, 42, 43]. 
 
Detailed factors associated with FCR in AYA cancer survivors were presented in Table 2. 
Thewes et al. [26] examined the relationship between a number of sociodemographic and 
clinical variables with levels of FCR. Results show that participant’s age, gender, education, 
living situation, occupational status, cancer type, phase of treatment, and cancer stage were 
not significantly related to recurrence fears [26]. Mattsson et al. [37] investigated 337 
gynecological cancer survivors and found that age at diagnosis, previous serious life events 
and have children or not did not have significant associations with FCR levels. However, 
multimodal treatment (such as surgery, and/or chemotherapy and/or radiotherapy) and a 
history of psychological distress significantly predicted cancer related distress, such as FCR. 
Inconsistent findings were reported by Shay and her colleagues. They found that FCR was 
associated with gender, employment and type of cancer. Survivors who were employed and 
less than 5 years from treatment were positively related to FCR, while thyroid cancer 
survivors, and those in clinical trial were less likely to report FCR [25]. 
 
Additionally, Lebel [35] concluded that younger age at diagnosis (less than 35) was 
associated with greater FCR than survivors in the other age categories. Wang et al. [42] 
revealed that female and higher treatment intensity were significantly associated with 
increased FCR. One study examined the relationship between spiritual distress and FCR in 
120 mixed AYA cancer survivors and found that spiritual struggle was significant positively 
related to FCR in a bivariate correlation analysis. However, this association disappeared 
when having undergone chemotherapy was controlled [43]. 
 
Consequences of FCR 
Eleven articles reported information about consequences of FCR [26, 30, 32-34, 36, 38-41, 
44]. A study [31] found that FCR was the foremost intense life change the AYA survivors had 
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experienced. Strong evidence has been found to support the relationship between high FCR 
and low Quality of Life [26, 33, 41]. Thewes et al. [26] found that adolescent and young adult 
cancer survivors who reported high FCR tended to report worse functioning in both 
psychological and social domains. Compared with survivors with low FCR, those who 
experienced higher FCR were also more likely to report higher anxiety levels, total 
psychological distress and lower overall health-related quality of life. However, no difference 
was found for depression, physical or religious functioning. Cho et al. [41] found that FCR 
was significant negatively associated with both mental and physical health related QoL. 
Additionally, the negative relationship between FCR and mental health-related QoL was 
moderated by perceived growth. 
 
Poort and colleagues [44] examined the association between FCR and fatigue severity by the 
Cancer Worry Scale and Checklist Individual Strength (CIS-fatigue). Findings revealed that 
higher FCR was moderately correlated to fatigue severity [44]. Studies also found that FCR 
may lead to decreased breast self-examination frequency [32] and less nicotine dependence 
[40]. Compared to younger adolescents (aged 12-15), older adolescents (aged 16-18) are 
less likely to perform breast self-examination because of general fear about cancer and FCR. 
 
In addition, FCR may also influence AYA survivor’s attitude towards future pregnancy and 
parenting, one study showed that more than one third of the participants did not want to 
have additional children because of FCR [36]. However, other studies indicated that FCR did 
not significantly affect an individual’s attitude towards self-image or life outlook, and Puukko 
et al. [30] indicated that FCR was not related to the frequency of somatic symptoms in AYA 
cancer survivors. Consequences of FCR in AYA cancer survivors are summarized in Table 3. 
 
4. Discussion 
Even though FCR study has expanded progressively over the last decade, there are only a 
few studies that focus specifically on FCR in AYA cancer survivors. To our best knowledge, at 
least three reviews of the literature have been conducted in AYAs to investigate their post-
treatment outcomes, Quality of Life, as well as the influence of psychosocial interventions 
[45-47]. However, this is the first review to explore FCR in AYAs. It has been frequently 
reported that younger age is significantly associated with higher levels of FCR [17]. 
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Therefore, we believe it is of importance to systematically explore the prevalence, correlates 
and potential consequences of FCR in this special population group. 
 
Of the 17 included articles, of which all, but one, received a strong overall quality rating, 
three concentrated specifically on breast cancer survivors, and one on leukemia. It has been 
found that the incidence of specific cancer types varies according to age [28]. For example, 
leukemia, lymphoma, testicular cancer, and thyroid cancer are the most common cancers 
among 15-24-year-olds, and among 25-39-year-olds, breast cancer and melanoma are the 
most common. Our review also found that all of the included studies were conducted in 
North America or European counties, which indicated that Asian countries have not 
provided sufficient attention on FCR in AYA survivors. 
 
Prevalence of FCR 
The prevalence data on FCR is inconsistent. Simard et al. [17] reported that around 39% to 
97% (on average 73%) of adult cancer survivors reported some degree of FCR and 0% to 15% 
(on average 7%) reported high degree. In the current review, we found 29% to 85.2% of AYA 
survivors reported some level of FCR, and 13% to 62% reported high level. The 
interpretation of the prevalence across studies is challenging as many studies utilized single 
question/unvalidated study-designed scales which provided limited psychometric evidence. 
In addition, no consensus is available about the definition of AYA or what constitutes clinical 
levels of FCR. 
 
One study found that there was a slight increase in FCR over time in AYA cancer population. 
A recent study followed adult breast cancer patients soon after primary surgery and 
assessed FCR at baseline, 6 and 18 months follow up [48]. They reported that FCR was stable 
for the first 6 months but at 1.5 years increased in younger compared to older patients. 
Another study by Manne and colleagues [49] found that nearly 50% of the adult patients 
diagnosed with gynecological cancer continued to experience a high level of FCR (high-
stable) 6 months after cancer diagnosis, and about 25% of them reported decreasing FCR 
over time (high-decreasing) while the remaining 25% reported consistently low FCR (low-
stable). 
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Determinants of FCR 
Most the demographic and clinical factors were found to be not significantly associated with 
levels of FCR in AYAs, but weak evidence emerged for gender, treatment intensity and 
psychological distress. Even though only two studies suggested that female experienced 
greater fear than male AYAs, this finding is consistent with several studies in adult cancer 
patients [13, 50-52]. However, many contrary findings were also reported. In Simard’s review 
[17], a total of 12 studies found no relationship between gender and FCR in adults. In our 
current review, one study also reported a nonsignificant association [26]. Further research is 
needed to better understand the association between gender and FCR. 
 
Our finding showed that different treatment type (i.e. surgery) was unrelated to FCR, but 
higher treatment intensity was significantly associated with increased FCR. Some previous 
studies identified radiotherapy/chemotherapy as predictors of higher FCR, however, this 
relationship tended to disappear in multivariate analyses [53, 54]. One possible reason is 
that those who were more intensively treated may have greater awareness and more 
knowledge about risks for chronic health complications. Another reason may be the 
treatment-related symptoms/side effects, such as tiredness, nausea, and skin reaction 
caused by radiotherapy and chemotherapy. It has been found that physical and cognitive 
impairments through treatment side effects could greatly contribute to elevated FCR [55]. 
Higher treatment intensity and longer treatment duration might cause more side effects. 
Those symptoms might be viewed by the patients as a constant reminder of their disease, 
which further leads to increased FCR [18]. 
 
Regarding psychological factors, there are a number of existing studies [56-59] that have 
demonstrated a moderate positive correlation between FCR and generalized anxiety, 
hypochondriasis, as well as depression. In particular, a strong association between 
depression, symptom distress and elevated FCR in adult cancer survivors has been 
consistently identified [23, 60]. 
 
Consequences of FCR 
Our review found that AYA cancer survivors with FCR were more likely to have impaired 
psychological functioning and overall health-related Quality of Life. As a common and 
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persistent concern, FCR was consistently found to have a detrimental effect on patient’s QoL 
[61, 62]. Simard et al. also reported a strong negative association between FCR and QoL or 
functional domains (i.e. mental, role, social and cognitive functioning etc.) in adult cancer 
populations [17]. It is reasonable to assume that unexpected cancer diagnosis and treatment 
may present great challenges to AYAs and may also influence their choices in education, 
marriage, and occupational pursuits in the future, which further worsen their psychological 
distress and impair their QoL [45-47]. Researchers believe that alleviating this concern could 
considerably help to improve patient’s life outcomes [62]. 
 
Clinical Implications 
It is of importance to ensure AYAs receive sufficient information and help on dealing with 
FCR. To date, several organizations have developed detailed guidelines for AYA cancer 
populations to provide better psychological service [46]. However, specific FCR interventions 
for AYAs are still lacking. Therefore, providing more attention to AYA populations and 
developing more specific psychological programs for them is necessary. Researchers 
suggested that AYA-specific programs should consist of a multidisciplinary group with 
professional knowledge and skills [63]. Besides traditional counsellors, religious peers, 
support groups and clinical psychologists, in particular, the team should include a highly 
motivated person with a professional interest in AYA oncology/survivorship (an ‘AYA 
champion’) [63]. It is believed that with this ‘champion’ the multidisciplinary team would 
identify better the unique needs of AYAs. In addition, routines assessment for FCR during 
clinical follow-up appointments could also greatly help to identify the problem. Early 
identification could lead to early intervention and management, and consequently improve 
the patient’s life outcomes. 
 
This review also highlighted significant implications in the clinical research of FCR in AYAs. 
First, the instruments to adequately measure FCR in AYA cancer survivors are not 
satisfactory. All the existing FCR measurements were developed based on adult cancer 
populations. Hence some reassurance that these measures have good psychometric 
properties for AYAs would be beneficial. Second, there is a need for further investigation on 
FCR in more diverse samples, particularly in Asian AYA populations. Third, longitudinal 
studies that can monitor the change of FCR over time and to further identify causal 
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associations are warranted. The majority of the FCR studies used cross-sectional designs, 
therefore, limited the examination of the development of FCR, and the dynamics of the 
relationship between FCR and psychosocial consequences. Better understanding of FCR in 
AYAs would be beneficial for developing AYA-specific programs in health care institutions. 
 
Study Limitations 
There are several limitations in this review that require consideration. First, the overall target 
sample is homogenous (all white, from north America or European countries). This may 
preclude generalization to other populations. Also, most of the included studies were cross-
sectional and the sample size varied significantly (ranged from 20 to 1395). Out of the 
seventeen included studies, ten of them were published after Simard’s robust review in 
2013 and seven were published recently within three years. However, there is still an overlap 
between the studies included in the current review and those in previous reviews. The 
number of scale items also varied widely and FCR was assessed using a range of 
measurements among the included studies, additionally, insufficient efforts have been made 
to establish standard clinical cut-offs of FCR. Finally, no attempt was made to search for non-
English articles or unpublished articles, and qualitative studies were excluded in the current 
review. Therefore, we suggest that these results should be interpreted with caution. 
 
5. Conclusion 
FCR is a prevalent concern among AYA population but it has not been adequately assessed or 
research advanced enough to establish design criteria for development of targeted 
interventions to manage FCR for this specialist group of patients. Longitudinal studies in 
AYAs are needed to examine further the long-term development and influence of FCR. Age-
appropriate and flexible psychological care services are likely to be indicated from this more 
advanced information base, if initial speculation from this review is confirmed. Decreasing 
FCR may lead to improved Quality of Life and better adherence to cancer surveillance, 
therefore, increased attention should be targeted at AYA cancer survivors. 
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Table 1 Characteristics of included studies 
-Author  
-Year 
Country Study Design Cance
r Type 
N 
(female %) 
-Age at 
Diagnosis 
-Age at Survey 
Mean (SD) a 
Time since 
Diagnosis 
Mean (SD) a 
Instrument Main finding (FCR Prevalence, 
Determinants, and consequence) 
-Thewes 
[26] 
-2018 
Netherland
s 
Cross-
sectional 
Mix 73 (51%) -27.4 (4.6), 
range from 18 to 
35 
-NR 
1.9 (2.6) CWS -Prevalence: 62% reported high FCR 
-Determinants: sociodemographic and 
clinical variables were not significantly 
associated with levels of FCR 
-Consequence: High FCR was associated 
with lower psychological, social 
functioning and overall QoL (P<0.01) 
-Mattsson 
-2018 [37] 
Sweden Cross-
sectional 
gynec
ologic
al 
337 
(100%) 
-32.6 (4.9), 
range from 19 to 
39 
-36.9 (5.1) 
2.9 (1.9) Study-
specific 
questionnair
e 
-Prevalence: 61% reported FCR 
-Determinants: multimodal treatment 
(OR=2.25) and a history of 
psychological distress (OR=3.44) 
predicted cancer related distress 
(including FCR) 
-Poort 
-2017 [44] 
Netherland
s 
Cross-
sectional 
Mix 83 (48%) -27.3 (4.4), 
range from 18 to 
35 
-29.4 (4.7) 
2.1 (2.6) CWS -Consequence: higher FCR was 
moderate correlated with severe 
fatigue (r’s: 0.30-0.50, P<0.01) 
-Park [43] 
-2017 
US Cross-
sectional + 
follow up 
Mix 120 
(77.9%) 
-28.9 (6.8), 
range from 15 to 
39 
-32.6 (7.4) 
3.8 (3.0) CARS -Determinants: spiritual struggle was 
positively associated with FCR (r=0.24, 
P=0.04) 
-Cho [41] 
-2017 
US Cross-
sectional 
Mix 292 
(80.5%) 
-range 15-34 
-33.3 (7.1) 
3.8 (2.5) ASC -Prevalence: 49.1% reported moderate-
to- high FCR, 13% reported high FCR 
-Consequence: FCR was negatively 
related to both physical (P=0.01) and 
mental health-related QoL (P<0.001) 
-Shay [25] 
-2016 
US Cross-
sectional 
Mix 1395 
(59.7%) 
-30.0 (6.6), 
range from 15 to 
39 
NR Single item 
from the QoL 
in Adult 
-Prevalence: 85.2% reported FCR 
-Determinants: being employed, less 
than 5yrs off treatment were positively 
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-38 (range 18-
73) 
Cancer 
Survivors 
Scale 
related to FCR; thyroid cancer patients, 
and those in clinical trial were less likely 
to report FCR 
-Kremer 
[38] 
-2016 
Germany Cross-
sectional 
NR 33 (45.5%) -8.1 (5.1), range 
from 0 to 18 
-23.8 (3.8), 
range from 18 to 
34 
NR Fear of 
disease 
Progression 
questionnair
e-short form 
-Consequence: posttraumatic growth 
was experienced by AYAs, FCR reported 
by Childhood cancer survivors was 
lower than AYA patients with type 1 
diabetics (P<0.001) 
-Wang [42] 
-2015 
Canada Cross-
sectional 
Mix 250 (46%) -range 0-17 
-range 15-26 
NR 6-item CWS -Prevalence: 7% strongly worry about 
relapse and 31% reported moderate 
FCR 
-Determinants: female and higher 
treatment intensity were associated 
with higher cancer worry 
-Senkus 
-2014 [36] 
US Cross-
sectional 
Breast 389 
(100%) 
-aged < 36 
-NR 
0.5 (NR) Interview 
question 
-Consequence: 36% survivors who did 
not want additional children because of 
FCR 
-Seitz [39] 
-2014  
Germany Cross-
sectional + 
follow up 
Mix 20 (70%) -NR 
-27.3 (4.8), 
range from 20 to 
36 
13.8 (4.7) FoP-SF -Consequence: 45% of the survivors 
showed an improvement on FCR after 
an internet-based CBT intervention 
(P=0.031) 
-Lebel [35] 
-2013 
Canada Cross-
sectional 
Breast 100 
(100%) 
-NR 
-aged < 35 
2.87 (3.94) CARS -Determinants: younger age at 
diagnosis (< 35) was associated with 
increased FCR than women in the other 
age categories 
-de Moor 
-2011 [40] 
US Cross-
sectional 
Mix 374 (49%) -aged < 35 
-32.4 (7.94) 
range from 18 
to 55 
20 (9.61) Single 
question 
from IES 
-Consequence: survivors who did not 
have FCR were more likely to be 
nicotine dependent (OR=2.08, 95%CI: 
0.81, 5.32) 
-Cox [32] 
-2008 
US Cross-
sectional + 
follow up 
Breast 149 
(100%) 
-NR 
-median=15, 
range from 12-
19 
Median=11.
72, range 
2.23-16.89 
Single item -Prevalence: 29% reported FCR at 
baseline, and 31% reported FCR one 
year later 
-Consequence: FCR predicted 
decreased breast self-examination 
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frequency 
-Zebrack 
-2002 [34] 
US Cross-
sectional 
Mix 176 
(57.4%) 
-8.5 (5.1), range 
from 0 to 22 
-21.8 (3.3), 
range from 16 to 
28 
13.3 (5.7) Items from 
Quality of 
life-cancer 
survivors 
-Consequence: FCR was associated with 
low overall quality of life in AYAs 
(r=0.745) 
-Zebrack 
-2001 [33] 
US Cross-
sectional 
Mix 303 (53%) -8.6 (5.18), 
range from 0 to 
22 
-20.0 (3.39), 
range from 14 to 
29 
11.3 (5.76) Self-designed 
items 
-Consequence: cancer specific worry 
(including FCR) did not significantly 
predict survivors’ self-image or life 
outlook. 
-Puukko 
-1998 [30] 
Finland Cross-
sectional 
leuke
mia 
42 (100%) -7.4 (3.4) 
-18.6 (3.9) 
NR Two 
questions 
-Prevalence: 52% reported FCR 
-Consequence: FCR was unrelated to 
frequency of somatic symptoms 
-Roberts 
-1997 [31] 
US Cross-
sectional 
Mix 46 (NR) -NR 
-31.4 (4.0), 
range from 22 to 
35 
4.3 (2.7) Single item -Consequence: FCR was the most 
intense life changes the survivors had 
experienced (degree of change=6.78) 
a mean (SD) in years; Abbreviation: NR: Not Report; FCR: Fear of Cancer Recurrence; QoL: Quality of Life; CWS: Cancer Worry Scale; CARS: Concerns About Recurrence Scale; 
ASC: Assessment of Survivor Concerns; FoP-SF: Fear of Progression Questionnaire-short form; IES: Impact of Event Scale
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Table 2 Factors associated with FCR in AYA cancer survivors 
a Mean or frequency comparison analysis, b Multivariate regression model analysis, c Clinically relevant 
difference, d Correlations, AYA: adolescent and young adult 
 
Factors Nil Positive association Negative association 
Demographic    
Gender (Female) [26] a [25] b, [42] b  
Age at survey (years)   [25] b 
Race (white/other) [25] a, [42] a   
Employment (Yes/No) [26] a [25] b  
Education level [25] a, [26] a, [42] a   
Married/Partnered [25] b, [26] a   
Have children (Yes/No) [26] a, [37] b   
Living situation [26] a   
Total household income [25] a   
Insurance status [25] a   
Clinical/Treatment    
Age at diagnosis (Years) [26] a   [35] a, [37] b 
Time since diagnosis (Years) [26] a, [42] a   
Cancer type [26] a, [42] b   
Cancer stage [26] a   
Treatment status (On/off) [26] a   
Surgery (Yes/No) [25] b, [26] a   
Radiotherapy (Yes/No) [25] b, [26] a   
Chemotherapy (Yes/No) [26] a [43] b  
Hormonal therapy (Yes/No) [26] a   
Immunotherapy (Yes/No)  [26] a  
Number of treatment(s)  [37] b, [42] b  
Less than 5 yrs off treatment  [25] b  
Thyroid cancer   [25] b 
In clinical trail   [25] b 
Currently seeing a doctor [25] b   
Relapse status (Yes/No) [42] a   
Psychological    
Anxiety  [26] ac  
Depression [26] ac   
Psychological distress  [26] ac  
Past psychological distress  [37] b  
Previous serious life events [37] b   
Spiritual struggle  [43] d  
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Table 3 Consequences of FCR in AYA cancer survivors 
a Mean or frequency comparison analysis, b Multivariate regression model analysis, c Clinically relevant 
difference, d Correlations, AYA: adolescent and young adult, QoL: Quality of Life 
 
Consequences Nil Positive association Negative association 
Quality of Life    
Physical functioning [26] ac  [41] d 
Psychological functioning   [26] ac, [41] d 
Social functioning   [26] ac 
Religious functioning [26] ac   
Overall health-related QoL   [26] ac, [34] d 
Other outcomes    
Nicotine dependent (Yes/No)   [40] b 
Breast self-examination   [32] a 
Somatic symptoms frequency [30] d   
Have additional children   [36] 
Fatigue severity  [44] d  
Self-image [33] b   
Life outlook [33] b   
